Operating Lease, Right-of-Use Asset of Regulus Therapeutics Inc. from 01 Jan 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Regulus Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Mar 2025.
  • Regulus Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $1,988,000, a 49% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Regulus Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,988,000 +$658,000 +49% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $874,000 -$603,000 -41% 31 Dec 2024 10-Q 08 May 2025 2025 Q1
Q3 2024 $1,028,000 -$593,000 -37% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,181,000 -$582,000 -33% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,330,000 -$572,000 -30% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $1,477,000 -$562,000 -28% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $1,621,000 -$553,000 -25% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,763,000 -$543,000 -24% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $1,902,000 -$534,000 -22% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,039,000 -$525,000 -20% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $2,174,000 -$516,000 -19% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $2,306,000 -$508,000 -18% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $2,436,000 -$533,000 -18% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $2,564,000 +$2,311,000 +913% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $2,690,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $2,814,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $2,969,000 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $253,000 -$211,000 -45% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q4 2019 $464,000 -$2,836,000 -86% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $510,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $0 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $0 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $3,300,000 01 Jan 2019 10-Q 12 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.